Skip to content
The Policy VaultThe Policy Vault

Qbrexza (glycopyrronium cloth 2.4% for topical use)Cigna

Primary Axillary Hyperhidrosis

Initial criteria

  • Patient is age ≥ 9 years; AND
  • Hyperhidrosis is significantly interfering with the ability to perform age-appropriate activities of daily living; AND
  • The prescriber has excluded secondary causes of hyperhidrosis; AND
  • Patient meets ONE of the following (i or ii):
  • i. Patient has tried one prescription aluminum chloride-containing topical antiperspirant for at least 4 weeks and experienced inadequate efficacy; OR
  • ii. According to the prescriber, the patient has experienced significant intolerance with an aluminum-containing topical antiperspirant.

Approval duration

1 year